TUNG v. BRISTOL-MYERS SQUIBB CO.

18-CV-1611 (JPO).

412 F.Supp.3d 453 (2019)

Jennifer TUNG et al., Plaintiffs, v. BRISTOL-MYERS SQUIBB COMPANY et al., Defendants.

United States District Court, S.D. New York.

Signed September 30, 2019.

Editors Note
Applicable Law: 15 U.S.C. § 78j(b)ss
Cause: 15 U.S.C. § 78j(b)ss Stockholder Suit
Nature of Suit: 850 Securities / Commodities
Source: PACER


Attorney(s) appearing for the Case

Joseph Alexander Hood, II , Jeremy Alan Lieberman , Pomerantz LLP, New York, NY, William H. Narwold , Motley Rice LLC, Hartford, CT, for Plaintiffs.

Yosef J. Riemer , Matthew Osborn Solum , Kirkland & Ellis LLP, New York, NY, for Defendants.


OPINION AND ORDER

In 2014, Defendant Bristol-Myers Squibb Company announced a clinical trial to test the efficacy of one of its newest anticancer drugs. The trial failed, which precipitated a drop in the company's stock price. Plaintiffs now bring this putative shareholder class action, alleging that public...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases